|
Volumn 6, Issue 2, 1997, Pages 173-180
|
Antimicrobial management of Helicobacter pylori-associated gastrointestinal tract disease.
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTACID AGENT;
ANTIINFECTIVE AGENT;
ANTIULCER AGENT;
CLINICAL TRIAL;
DRUG COMBINATION;
DRUG EFFECT;
ECONOMICS;
GASTROINTESTINAL DISEASE;
HELICOBACTER PYLORI;
HUMAN;
MICROBIOLOGY;
REVIEW;
RISK FACTOR;
ANTACIDS;
ANTI-BACTERIAL AGENTS;
ANTI-ULCER AGENTS;
CLINICAL TRIALS;
DRUG THERAPY, COMBINATION;
GASTROINTESTINAL DISEASES;
HELICOBACTER PYLORI;
HUMANS;
RISK FACTORS;
|
EID: 0031092312
PISSN: 10633987
EISSN: None
Source Type: Journal
DOI: 10.1001/archfami.6.2.173 Document Type: Review |
Times cited : (6)
|
References (0)
|